mevalonic acid has been researched along with Proteinuria in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fried, LF | 1 |
Brunskill, NJ; Chana, RS; Sidaway, JE | 1 |
Christensen, M; Greco, A; Lipschutz, JH; Madaio, MP; Snyder, RW; Su, AW | 1 |
1 review(s) available for mevalonic acid and Proteinuria
Article | Year |
---|---|
Effects of HMG-CoA reductase inhibitors (statins) on progression of kidney disease.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Kidney Failure, Chronic; Mevalonic Acid; Models, Biological; Proteinuria | 2008 |
2 other study(ies) available for mevalonic acid and Proteinuria
Article | Year |
---|---|
Statins but not thiazolidinediones attenuate albumin-mediated chemokine production by proximal tubular cells independently of endocytosis.
Topics: Albumins; Animals; Cells, Cultured; Chemokine CCL5; Chemokines; Endocytosis; Epithelial Cells; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney Tubules, Proximal; Mevalonic Acid; Mice; Mice, Inbred C57BL; Polyisoprenyl Phosphates; Prostaglandin D2; Proteinuria; Serum Albumin, Bovine; Thiazolidinediones | 2008 |
Simvastatin protection against acute immune-mediated glomerulonephritis in mice.
Topics: Acute Disease; Animals; Blood Urea Nitrogen; Disease Progression; Dose-Response Relationship, Drug; Female; Glomerulonephritis; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney; Mevalonic Acid; Mice; Mice, Inbred C57BL; Proteinuria; Severity of Illness Index; Simvastatin | 2006 |